From: Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance
Diameter of the inhibitory zone (mm) Mean ± SEM (n = 5) | |||||||
---|---|---|---|---|---|---|---|
Antibiotic | Control | Antibiotic + SR 10  μg ml −1 | Antibiotic + SR 20 μg ml −1 | Antibiotic + SR 40 μg ml −1 | Antibiotic + SR 60 μg ml −1 | Antibiotic + SR 80 μg ml −1 | Antibiotic + SR 100 μg ml −1 |
Ciprofloxacin 5 μg | 20 ± 0.00 | 20.8 ± 0.20 | 22 ± 2.82 | 26 ± 2.82 | 29 ± 2.82* | 33 ± 2.82** | 40 ± 2.82*** |
Levofloxacin 5 μg | 22 ± 1.41 | 23.0 ± 0.50 | 24 ± 1.41 | 27 ± 1.41* | 30 ± 1.41** | 37 ± 1.41*** | 41 ± 0.00*** |
Norfloxacin 10 μg | 20 ± 0.00 | 21 ± 0.70 | 24.5 ± 0.70** | 26.50 ± 0.70*** | 30.50 ± 0.70*** | 33.5 ± 0.70*** | 39.5 ± 0.70*** |
Moxifloxacin 5 μg | 24 ± 1.41 | 24 ± 0.50 | 26 ± 1.41 | 28 ± 1.41 | 32 ± 1.41** | 36 ± 1.41*** | 42.5 ± 0.70*** |
Cefexime 5 μg | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 |
Cloxacillin 5 μg | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 | 0 ± 0.00 |
Gentamicin 10 μg | 24.50 ± 70 | 25 ± 0.50 | 26.50 ± 0.70 | 29.50 ± 0.70* | 33.50 ± 0.70*** | 38.50 ± 0.70*** | 41.5 ± 0.70*** |